Our Pricing

Complete Guide: How To Use Wegovy Pen For First Injection Safely

Learning how to use wegovy pen first injection uk correctly ensures optimal treatment outcomes and minimises injection site reactions. At Cured Pharmacy, our UK-registered clinical team has guided thousands of patients through their first Wegovy injection, and this comprehensive guide provides the exact step-by-step technique recommended by our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Understanding Your Wegovy Pen Before First Injection

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone regulating appetite and blood sugar [1]. Each pre-filled pen delivers a precise dose subcutaneously, designed for once-weekly administration. The starting dose is always 0.25mg for the first four weeks, regardless of your target maintenance dose.

Before your first injection, familiarise yourself with the pen components: the dose counter window (showing your prescribed dose), the injection button (which clicks when pressed fully), and the protective cap covering the needle. Wegovy pens are single-use devices—each pen contains one dose and must be disposed of after use in a sharps container [2].

Store unopened Wegovy pens in the refrigerator between 2°C and 8°C. Once you remove a pen from the fridge for injection, let it reach room temperature for 30 minutes—cold injections can cause unnecessary discomfort. Never freeze Wegovy or use a pen that has been frozen, as this degrades the active semaglutide molecule.

How To Use Wegovy Pen First Injection: Step-By-Step Instructions

Wash your hands thoroughly with soap and water. Gather your supplies: the Wegovy pen, an alcohol wipe, cotton wool or gauze, and your sharps disposal container. Check the pen's dose counter matches your prescribed dose (0.25mg for first injection) and inspect the liquid through the viewing window—it should be clear and colourless [3].

Choose your injection site: abdomen (at least 5cm away from your belly button), front of thighs, or upper arm. Rotate sites each week to prevent lipohypertrophy—tissue thickening that reduces medication absorption. Clean the chosen area with an alcohol wipe and allow it to dry completely for 10 seconds.

Remove the pen cap by pulling it straight off. You'll see the needle—do not touch it. Pinch a fold of skin firmly between your thumb and forefinger. Hold the pen at a 90-degree angle to your skin and press the injection button firmly until you hear a click. Keep holding the button down and count slowly to six—this ensures the full dose is delivered subcutaneously [3].

After six seconds, release the button and withdraw the needle straight out. A small drop of blood or clear fluid may appear—this is normal. Apply gentle pressure with cotton wool if needed, but do not rub the injection site. Immediately place the used pen in your sharps container without recapping the needle.

Common First Injection Mistakes To Avoid

The most frequent error is not holding the injection button down for the full six seconds. Releasing early means you receive a partial dose, which compromises treatment efficacy. Set a timer or count 'one Mississippi, two Mississippi' to ensure accurate timing.

Another common mistake is injecting through clothing or into muscle rather than subcutaneous fat. Always inject into bare skin after proper cleaning, and ensure you're pinching enough tissue—if you can only grasp a thin layer, choose a different site with more subcutaneous fat like the abdomen.

What To Expect After Your First Wegovy Injection

Mild injection site reactions occur in approximately 5-10% of patients and typically resolve within 48 hours [1]. You may notice slight redness, swelling, or tenderness at the injection site—these are normal immune responses and don't indicate allergy or infection. Apply a cool compress if discomfort persists.

Gastrointestinal side effects are most common during the first four weeks as your body adjusts to semaglutide. In the STEP clinical trials, approximately 44% of participants experienced mild nausea, particularly after the first few injections [1]. This typically diminishes significantly by week 8-12 as tolerance develops.

The gradual dose escalation schedule (starting at 0.25mg) specifically minimises these side effects whilst allowing your body to adapt. You'll increase to 0.5mg at week 5, then progress through higher doses every four weeks until reaching your maintenance dose—either 1.7mg or 2.4mg depending on your prescriber's assessment [2].

Wegovy Injection Technique: Best Practices From UK Pharmacists

Injection depth matters significantly for semaglutide absorption. Wegovy must be administered subcutaneously—into the fatty tissue layer beneath the skin but above muscle. If you're lean with minimal subcutaneous fat, pinch firmly and consider injecting at a 45-degree angle rather than 90 degrees to avoid intramuscular injection [3].

Temperature affects both comfort and absorption. Room-temperature Wegovy (15-25°C) causes significantly less injection site pain than refrigerated pens. If you forget to remove your pen from the fridge early, hold it in your hands (not under hot water) for 10-15 minutes before injection.

Site rotation prevents lipohypertrophy and ensures consistent absorption rates. Keep a simple log noting which site you used each week—abdomen left side, abdomen right side, left thigh, right thigh. Never inject into areas with visible lumps, scars, bruises, or stretch marks, as these affect medication distribution.

When To Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, or signs of allergic reaction (difficulty breathing, facial swelling, widespread rash). These are rare but require urgent assessment.

Contact your prescriber before your next injection if you experience severe injection site reactions lasting beyond 72 hours, signs of infection (increasing warmth, pus, red streaks), or if gastrointestinal side effects prevent you from maintaining adequate nutrition and hydration. Your dose escalation schedule may need adjustment.

Wegovy Pen Storage And Disposal Guidelines UK

Proper storage maintains semaglutide stability and treatment efficacy. Unopened Wegovy pens must remain refrigerated at 2-8°C until first use—store them in the main body of your fridge, not the door where temperature fluctuates. Keep pens in the original carton to protect from light exposure.

Once in use, you may store your Wegovy pen at room temperature (up to 30°C) for up to 28 days if needed, though refrigeration remains preferable. This flexibility helps during travel—use an insulated medication travel case with ice packs for journeys exceeding a few hours. Never leave Wegovy in direct sunlight or in hot cars.

UK regulations require sharps disposal in designated containers—never throw used pens in household waste. Obtain a sharps bin from Cured Pharmacy, your local council, or any UK pharmacy. When three-quarters full, seal the container and return it to your local pharmacy or council collection point for safe incineration. Some councils offer free home collection services for patients on long-term injectable treatments.

How To Use Wegovy Pen First Injection Alongside Lifestyle Changes

Wegovy works synergistically with dietary modifications and increased physical activity—it's not a standalone solution. Clinical trials demonstrating the 14.9% average weight reduction at 68 weeks included participants following a reduced-calorie diet and 150 minutes weekly exercise [1]. Semaglutide reduces appetite and food cravings, making it significantly easier to maintain these lifestyle changes.

Start your first injection alongside sustainable dietary adjustments rather than extreme restriction. Focus on protein-rich meals (which enhance satiety alongside GLP-1 effects), increase fibre intake gradually to support digestive health, and prioritise hydration—aim for 2-3 litres daily as adequate fluid intake reduces nausea severity.

At Cured Pharmacy, Wegovy treatment starts from £79.00 and includes free clinical assessment by UK prescribers. Your consultation takes under three minutes, and our clinical team provides personalised guidance on optimising your injection technique and managing any side effects throughout your treatment journey.

Monitoring Your Progress On Wegovy

Weigh yourself weekly at the same time of day (ideally first thing in the morning after using the toilet, before eating). Weight fluctuates naturally by 1-2kg daily due to fluid retention, so focus on the overall monthly trend rather than day-to-day changes.

Beyond the scales, monitor non-scale victories: clothing fit, energy levels, blood pressure improvements, and changes in hunger patterns. Take progress photos monthly and track measurements (waist, hips, chest) as body composition changes often precede significant scale movements, particularly if you're incorporating resistance training.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
3. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide (Wegovy): Guidance for Healthcare Professionals on Subcutaneous Injection Technique. GOV.UK. https://www.gov.uk/drug-safety-update/semaglutide

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and must be prescribed by a UK-registered clinician following appropriate clinical assessment.